Skadden is representing contract drug manufacturer Catalent, Inc. in its $16.5 billion acquisition by Novo Holdings A/S.
by Rohin Pujari
Home »
Press Releases » US – Catalent To Be Acquired By Novo Holdings.
Conventus Law
Conventus Law
Register for your monthly Asia legal updates from Conventus Law
Error: Contact form not found.
RELATED ARTICLES
October 31, 2024
10 Opinions On 2024’s Biggest Developments In e-Discovery.
October 30, 2024
Legal Intake Forms: How To Capture Information Efficiently And Accurately.
- Sacha Kirk - Lawcadia,
Footer
